Yamaguchi H, Nagamura Y, Miyazaki M
Cancers (Basel). 2022; 14(15).
PMID: 35954414
PMC: 9367326.
DOI: 10.3390/cancers14153750.
Shirakihara T, Yamaguchi H, Kondo T, Yashiro M, Sakai R
Oncogene. 2022; 41(18):2587-2596.
PMID: 35338344
DOI: 10.1038/s41388-022-02270-5.
Xiang H, Chan A, Ahene A, Bellovin D, Deng R, Hsu A
MAbs. 2021; 13(1):1981202.
PMID: 34719330
PMC: 8565817.
DOI: 10.1080/19420862.2021.1981202.
Nagamura Y, Miyazaki M, Nagano Y, Tomiyama A, Ohki R, Yanagihara K
Cancers (Basel). 2021; 13(17).
PMID: 34503119
PMC: 8430696.
DOI: 10.3390/cancers13174309.
Ferguson H, Smith M, Francavilla C
Cells. 2021; 10(5).
PMID: 34068954
PMC: 8156822.
DOI: 10.3390/cells10051201.
What Are the Potential Roles of Nuclear Perlecan and Other Heparan Sulphate Proteoglycans in the Normal and Malignant Phenotype.
Hayes A, Melrose J
Int J Mol Sci. 2021; 22(9).
PMID: 33922532
PMC: 8122901.
DOI: 10.3390/ijms22094415.
PLEKHA5 regulates the survival and peritoneal dissemination of diffuse-type gastric carcinoma cells with Met gene amplification.
Nagamura Y, Miyazaki M, Nagano Y, Yuki M, Fukami K, Yanagihara K
Oncogenesis. 2021; 10(3):25.
PMID: 33677467
PMC: 7936979.
DOI: 10.1038/s41389-021-00314-1.
Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer.
Yashiro M, Kuroda K, Masuda G, Okuno T, Miki Y, Yamamoto Y
Sci Rep. 2021; 11(1):4698.
PMID: 33633310
PMC: 7907198.
DOI: 10.1038/s41598-021-84107-x.
Crosstalk Between Cancer Associated Fibroblasts and Cancer Cells in Scirrhous Type Gastric Cancer.
Miki Y, Yashiro M, Moyano-Galceran L, Sugimoto A, Ohira M, Lehti K
Front Oncol. 2020; 10:568557.
PMID: 33178597
PMC: 7596590.
DOI: 10.3389/fonc.2020.568557.
Application of "Tissueoid Cell Culture System" Using a Silicate Fiber Scaffold for Cancer Research.
Murakami S, Mukaisho K, Iwasa T, Kawabe M, Yoshida S, Taniura N
Pathobiology. 2020; 87(5):291-301.
PMID: 32966983
PMC: 7677999.
DOI: 10.1159/000509133.
Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis.
Zhang J, Tang P, Zhou Y, Cheng A, Yu J, Kang W
Cells. 2019; 8(6).
PMID: 31242658
PMC: 6627225.
DOI: 10.3390/cells8060637.
Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity.
Ansari S, Gantuya B, Tuan V, Yamaoka Y
Int J Mol Sci. 2018; 19(8).
PMID: 30115886
PMC: 6121269.
DOI: 10.3390/ijms19082424.
Prognostic relevance of FGFR2 expression in stage II/III gastric cancer with curative resection and S-1 chemotherapy.
Hosoda K, Yamashita K, Ushiku H, Ema A, Moriya H, Mieno H
Oncol Lett. 2018; 15(2):1853-1860.
PMID: 29434882
PMC: 5776945.
DOI: 10.3892/ol.2017.7515.
Generation of high-affinity, internalizing anti-FGFR2 single-chain variable antibody fragment fused with Fc for targeting gastrointestinal cancers.
Borek A, Sokolowska-Wedzina A, Chodaczek G, Otlewski J
PLoS One. 2018; 13(2):e0192194.
PMID: 29420662
PMC: 5805272.
DOI: 10.1371/journal.pone.0192194.
Molecular heterogeneity in the novel fusion gene : Diversity of genomic breakpoints in gastric cancer with high-level amplifications at 11p13 and 10q26.
Okuda T, Taki T, Nishida K, Chinen Y, Nagoshi H, Sakakura C
Oncol Lett. 2017; 13(1):215-221.
PMID: 28123544
PMC: 5244987.
DOI: 10.3892/ol.2016.5386.
Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.
Inokuchi M, Murase H, Otsuki S, Kawano T, Kojima K
World J Surg Oncol. 2017; 15(1):2.
PMID: 28056982
PMC: 5217622.
DOI: 10.1186/s12957-016-1081-4.
IKKε and TBK1 expression in gastric cancer.
Lee S, Hong M, Cho J, Lee J, Kim K
Oncotarget. 2016; 8(10):16233-16242.
PMID: 27145266
PMC: 5369959.
DOI: 10.18632/oncotarget.9069.
Molecular alterations in gastric cancer with special reference to the early-onset subtype.
Skierucha M, Milne A, Offerhaus G, Polkowski W, Maciejewski R, Sitarz R
World J Gastroenterol. 2016; 22(8):2460-74.
PMID: 26937134
PMC: 4768192.
DOI: 10.3748/wjg.v22.i8.2460.
Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer.
Yashiro M, Matsuoka T
World J Gastroenterol. 2016; 22(8):2415-23.
PMID: 26937130
PMC: 4768188.
DOI: 10.3748/wjg.v22.i8.2415.
Fibroblast growth factors, old kids on the new block.
Li X, Wang C, Xiao J, McKeehan W, Wang F
Semin Cell Dev Biol. 2016; 53:155-67.
PMID: 26768548
PMC: 4875805.
DOI: 10.1016/j.semcdb.2015.12.014.